Form D Explorer

Source evidence

EVIA Life Sciences Inc. · 0002162667-26-000001

D filed Nov. 2, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
TOKYO
street1
MIDTOWN TOWER 18F
street2
9-7-1 AKASAKA, MINATO-KU
zipCode
107-6218
entityName
EVIA Life Sciences Inc.
entityType
Corporation
stateOrCountry
M0
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold700002number700002/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount5498154number5498154/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 623214651f7fb55c721cbdade36d0e6df7280cd24876a7aa91358df92c9e7b16. This proves extraction identity, not the accuracy of the filer's claims.